Screening of Serum Alkaline Phosphatase and Phosphate Helps Early Detection of Metabolic Bone Disease in Extremely Low Birth Weight Infants

Background: Extremely low birth weight (ELBW, <1,000 g) infants have a high risk of metabolic bone disease (MBD). Because of the late appearance of radiological signs, diagnosis of MBD in ELBW infants might be delayed, and its prevalence underestimated in this group of patients. This study ad...

Full description

Bibliographic Details
Main Authors: Hui Zhang, Qiong Jia, Meihua Piao, Yanmei Chang, Jinghui Zhang, Xiaomei Tong, Tongyan Han
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2021.642158/full
_version_ 1818915777574600704
author Hui Zhang
Qiong Jia
Meihua Piao
Yanmei Chang
Jinghui Zhang
Xiaomei Tong
Tongyan Han
author_facet Hui Zhang
Qiong Jia
Meihua Piao
Yanmei Chang
Jinghui Zhang
Xiaomei Tong
Tongyan Han
author_sort Hui Zhang
collection DOAJ
description Background: Extremely low birth weight (ELBW, <1,000 g) infants have a high risk of metabolic bone disease (MBD). Because of the late appearance of radiological signs, diagnosis of MBD in ELBW infants might be delayed, and its prevalence underestimated in this group of patients. This study adopted serial screening of serum alkaline phosphatase (ALP) and phosphate (P) of ELBW infants to determine whether such screening is helpful for the early detection of MBD.Materials and Methods: We performed a retrospective study of preterm infants with a gestational age ≤ 31 weeks and birth weight <1,000 g. MBD was absent (ALP ≤500 IU/L), mild (ALP >500 IU/L, P ≥4.5 mg/dL), and severe (ALP >500 IU/L, P <4.5 mg/dL); MBD was divided into early MBD (≤4 weeks after birth) and late MBD (>4 weeks after birth) according to the time of onset.Results: A total of 142 ELBW infants were included, with a median gestational age of 28.1 (26.5–29.7) weeks and a median birth weight of 875 (818–950) g. Seventy-three cases of MBD were diagnosed, and the total prevalence was 51.4% (mild MBD, 10.6%; and severe MBD, 40.8%). Male sex, breastfeeding, and sepsis would increase the risk of severe MBD. Most MBD in ELBW infants occurred at 3–4 weeks after birth. Sixty-two percent (45/73) of infants were diagnosed as having early MBD, which are diagnosed earlier than late MBD [24 (21–26) vs. 39 (36–41), t = −7.161; P < 0.001]. Male sex [odds ratio (OR), 2.86; 95% confidence interval (CI), 1.07–7.64; P = 0.036], initial high ALP levels (OR, 1.02; 95% CI, 1.01–1.03; P < 0.001), and breastfeeding (OR, 5.97; 95% CI, 1.01–25.12; P = 0.049) are independent risk factors for the development of early MBD.Conclusion: The risk of MBD among ELBW infants is very high. Most cases occurred early and were severe. Male sex, initial high ALP levels, and breastfeeding are closely related to the increased risk of early MBD. Serial screening of serum ALP and P helps early detection of MBD; it is recommended to start biochemical screening for ELBW infants 2 weeks after birth and monitor their biochemical markers weekly.
first_indexed 2024-12-20T00:07:40Z
format Article
id doaj.art-d7dde944f2104420bd19a5e4aeea8675
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-12-20T00:07:40Z
publishDate 2021-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-d7dde944f2104420bd19a5e4aeea86752022-12-21T20:00:36ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602021-04-01910.3389/fped.2021.642158642158Screening of Serum Alkaline Phosphatase and Phosphate Helps Early Detection of Metabolic Bone Disease in Extremely Low Birth Weight InfantsHui ZhangQiong JiaMeihua PiaoYanmei ChangJinghui ZhangXiaomei TongTongyan HanBackground: Extremely low birth weight (ELBW, <1,000 g) infants have a high risk of metabolic bone disease (MBD). Because of the late appearance of radiological signs, diagnosis of MBD in ELBW infants might be delayed, and its prevalence underestimated in this group of patients. This study adopted serial screening of serum alkaline phosphatase (ALP) and phosphate (P) of ELBW infants to determine whether such screening is helpful for the early detection of MBD.Materials and Methods: We performed a retrospective study of preterm infants with a gestational age ≤ 31 weeks and birth weight <1,000 g. MBD was absent (ALP ≤500 IU/L), mild (ALP >500 IU/L, P ≥4.5 mg/dL), and severe (ALP >500 IU/L, P <4.5 mg/dL); MBD was divided into early MBD (≤4 weeks after birth) and late MBD (>4 weeks after birth) according to the time of onset.Results: A total of 142 ELBW infants were included, with a median gestational age of 28.1 (26.5–29.7) weeks and a median birth weight of 875 (818–950) g. Seventy-three cases of MBD were diagnosed, and the total prevalence was 51.4% (mild MBD, 10.6%; and severe MBD, 40.8%). Male sex, breastfeeding, and sepsis would increase the risk of severe MBD. Most MBD in ELBW infants occurred at 3–4 weeks after birth. Sixty-two percent (45/73) of infants were diagnosed as having early MBD, which are diagnosed earlier than late MBD [24 (21–26) vs. 39 (36–41), t = −7.161; P < 0.001]. Male sex [odds ratio (OR), 2.86; 95% confidence interval (CI), 1.07–7.64; P = 0.036], initial high ALP levels (OR, 1.02; 95% CI, 1.01–1.03; P < 0.001), and breastfeeding (OR, 5.97; 95% CI, 1.01–25.12; P = 0.049) are independent risk factors for the development of early MBD.Conclusion: The risk of MBD among ELBW infants is very high. Most cases occurred early and were severe. Male sex, initial high ALP levels, and breastfeeding are closely related to the increased risk of early MBD. Serial screening of serum ALP and P helps early detection of MBD; it is recommended to start biochemical screening for ELBW infants 2 weeks after birth and monitor their biochemical markers weekly.https://www.frontiersin.org/articles/10.3389/fped.2021.642158/fullmetabolic bone diseasealkaline phosphatasephosphateextremely low birth weight infantspreterm infants
spellingShingle Hui Zhang
Qiong Jia
Meihua Piao
Yanmei Chang
Jinghui Zhang
Xiaomei Tong
Tongyan Han
Screening of Serum Alkaline Phosphatase and Phosphate Helps Early Detection of Metabolic Bone Disease in Extremely Low Birth Weight Infants
Frontiers in Pediatrics
metabolic bone disease
alkaline phosphatase
phosphate
extremely low birth weight infants
preterm infants
title Screening of Serum Alkaline Phosphatase and Phosphate Helps Early Detection of Metabolic Bone Disease in Extremely Low Birth Weight Infants
title_full Screening of Serum Alkaline Phosphatase and Phosphate Helps Early Detection of Metabolic Bone Disease in Extremely Low Birth Weight Infants
title_fullStr Screening of Serum Alkaline Phosphatase and Phosphate Helps Early Detection of Metabolic Bone Disease in Extremely Low Birth Weight Infants
title_full_unstemmed Screening of Serum Alkaline Phosphatase and Phosphate Helps Early Detection of Metabolic Bone Disease in Extremely Low Birth Weight Infants
title_short Screening of Serum Alkaline Phosphatase and Phosphate Helps Early Detection of Metabolic Bone Disease in Extremely Low Birth Weight Infants
title_sort screening of serum alkaline phosphatase and phosphate helps early detection of metabolic bone disease in extremely low birth weight infants
topic metabolic bone disease
alkaline phosphatase
phosphate
extremely low birth weight infants
preterm infants
url https://www.frontiersin.org/articles/10.3389/fped.2021.642158/full
work_keys_str_mv AT huizhang screeningofserumalkalinephosphataseandphosphatehelpsearlydetectionofmetabolicbonediseaseinextremelylowbirthweightinfants
AT qiongjia screeningofserumalkalinephosphataseandphosphatehelpsearlydetectionofmetabolicbonediseaseinextremelylowbirthweightinfants
AT meihuapiao screeningofserumalkalinephosphataseandphosphatehelpsearlydetectionofmetabolicbonediseaseinextremelylowbirthweightinfants
AT yanmeichang screeningofserumalkalinephosphataseandphosphatehelpsearlydetectionofmetabolicbonediseaseinextremelylowbirthweightinfants
AT jinghuizhang screeningofserumalkalinephosphataseandphosphatehelpsearlydetectionofmetabolicbonediseaseinextremelylowbirthweightinfants
AT xiaomeitong screeningofserumalkalinephosphataseandphosphatehelpsearlydetectionofmetabolicbonediseaseinextremelylowbirthweightinfants
AT tongyanhan screeningofserumalkalinephosphataseandphosphatehelpsearlydetectionofmetabolicbonediseaseinextremelylowbirthweightinfants